Neil Campbell
Board Member
Onconetix, Inc. (ONCO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Neil Campbell
Neil Campbell is recorded as Board Member and CEO at Onconetix, Inc. (ONCO). Onconetix, Inc. reported in an 8-K filed October 10, 2023 that Neil Campbell was appointed member of the Board of Directors, effective October 4, 2023. Onconetix, Inc. reported in an 8-K filed October 10, 2023 that Neil Campbell was appointed President and Chief Executive Officer, effective October 4, 2023. The proxy statement of Onconetix, Inc. reports total compensation of $163,814 for Neil Campbell in fiscal 2024, including a base salary of $5,481. Disclosed compensation is on record for 3 fiscal years.
“On October 4, 2023 (the “Effective Date”), Blue Water Biotech, Inc. (the “Company”) appointed Dr. Neil Campbell, 63, as President and Chief Executive Officer of the Company and as a member of the Board of Directors (the “Board”) of the Company, effective immediately.”
“On October 4, 2023 (the “Effective Date”), Blue Water Biotech, Inc. (the “Company”) appointed Dr. Neil Campbell, 63, as President and Chief Executive Officer of the Company and as a member of the Board of Directors (the “Board”) of the Company, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-10-04–present
-
Current
2023-10-04–present
-
Start not stated–2024-01-10
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Onconetix, Inc.
Other people whose current roles at this company are on record from its filings.
- David White CEO
- Dr. Ralph Schiess CEO
- Jon Garfield CEO
- Neil J. Campbell CEO, Board Member
- James Sapirstein Chairman, Board Member
- Sammy Dorf Chairman, Board Member
- Bruce Harmon CFO
- Karina Fedasz CFO
- Ajit Singh Board Member
- Andrew Oakley Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Onconetix, Inc. (ONCO) | Former Chief Executive Officer | $5,481 | $163,814 |
| 2023 | Onconetix, Inc. (ONCO) | Former Chief Executive Officer | $114,792 | $376,169 |
| 2022 | Onconetix, Inc. (ONCO) | Former Chief Executive Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.